Press Release
CSL signs enterprise agreement with BrightInsight following success of Hizentra app
CSL Behring leveraged the BrightInsight Platform® to launch a mobile app for adult patients with rare diseases who are taking Hizentra.
Read NowBrightInsight accelerates time to market for our customers’ digital health products, including apps, healthcare provider interfaces, analytics dashboards, algorithms, medical devices, connected combination products, diagnostics and Software as a Medical Device (SaMD) across therapeutic areas.
CSL Behring leveraged the BrightInsight Platform® to launch a mobile app for adult patients with rare diseases who are taking Hizentra.
Read NowBrowse our latest white papers, case studies, webinars and more
Contact us to set up a demo today.